Skip to main content

Table 3 Participant characteristics by message format condition

From: Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?

  Verbal-only (n = 69) Verbal and numerical combined (n = 72) p
n % n %
Gender
 Female 45 35 46 36  
 Male 24 65 26 64 .869
Age at time of experiment, mean (SD) 57.72 (7.29)   56.83 (7.50)   .469
 < 50 years 8 11 13 18  
 50–65 years 44 64 49 68  
 > 65 years 17 25 10 14 .201
Education
 Primary school 8 11 12 17  
 Secondary school 17 25 24 33  
College/University 44 64 36 50 .255
Tumor
 Breast 22 32 22 31  
 Hematologicala 13 19 8 12  
 Urologicalb 10 15 13 18  
 Gynecologicalc 7 10 10 14  
 Head and neck 4 6 6 8  
 Lung 2 3 4 5  
 Skin 3 4 2 3  
 Gastroenterologicald 3 4 2 3  
 Othere 3 4 4 5  
 Unknown 2 3 1 1 .912
Years since diagnosis, mean (SD) 6.48 (6.89)   5.01 (4.22)   .133
 0–5 years 43 62 52 72  
 6–10 years 12 17 13 18  
 11–15 years 8 12 5 7  
 > 15 years 6 9 2 3 .318
Treatment(s)      
 Surgery 48 70 48 67 .712
 Radiotherapy 40 58 35 49 .266
 Chemotherapy 40 58 37 51 .433
 Immunotherapy 13 19 11 15 .574
 Hormone therapy 18 26 24 33 .347
 Other 16 23 13 18 .451
Prior experience side effects
 Fatigue 55 80 49 68 .116
 Neuropathy 29 42 26 36 .471
 Smell and taste changes 30 44 27 38 .470
 Diarrhea 14 20 11 15 .436
 None of the above 7 10 9 13 .659
Subjective numeracy, mean (SD)f 4.51 (0.81)   4.64 (0.86)   .384
  1. aLymphoma, Leukemia, Multiple myeloma
  2. bProstate, bladder
  3. cUterus, cervix, ovary
  4. dEsophageal, anus, GIST, gall bladder, but excluding colorectal cancer
  5. eBrain, renal cell, undifferentiated pleomorphic sarcoma, neuroendocrine tumor
  6. fα = .82; SD standard deviation
\